Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including Section 122 tariffs and tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)
2026 · 3rd Quarter (July 1 - Sep 30)
HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
Filed by HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- Not reported
- Expenses
- $60,505.00
- Registrant
- HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION
- Filing UUID
- fb6d3775-50c4-456a-9e61-a6aa57fa20a1
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Medical Supply Chain Resiliency Act (S. 998/HR 2213). Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.